Incorporated in 2016, Lasa Supergenerics Ltd is in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, Pharmaceuticals, drugs, etc.
Lasa Supergenerics held a board meeting on August 14, 2026, where it approved the financial results for the quarter ended June 30, 2026. 1. **Financial Performance:** The company's operations remain severely impacted by a major fire in May 2025 at its primary, uninsured factory. This incident continues to halt all...